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14.1% (310/2,196). Of 1,674 CAs in general inpatient areas, 1,084 (64.8%) were M/W, S 
= 16.4% (178/1,084) vs 590 (35.2%) not M/W, S = 5.9% (35/590). p<0.001. VFNT was 
the initial rhythm in 27.1% of pulseless CA cases (S = 34.2%, 449/1,313); 24.9% of 
cases were PEA (S = 7.8%, 94/1,207); and 34.9% asystole (S = 7.8%, 131/1,692). S 
from VF/V"F was greater than PEA or asystole (p<0.001). Data for time to first shock was 
entered on 1,154 VFNT CAs. Serf reported time intervals indicated 84.3% of cases met 
the AHA goal of first shock < 3 min with S = 37.1% vs first shock >/= 3 min, S = 27.1% 
(p<0.05). Mean time to first shock for S was 0.85 +/- 1.70 min vs 1.31 +/- 2.94 min for 
non-S (p<0.001). Conclusion: Many hospitalized patients at high risk for CA are M/W. 
CA that are M/W have higher survival rates than those not M/W. Initial rhythm is VF/V'r in 
only 27%, a lower percentage than for out-of-hospital CA. Although there are known 
problems with accurate reporting of CA time intervals, 84.3% self-reported achieving the 
AHA benchmark of < 3 min to first shook. Shorter time to initial shock is significantly 
associated with S from VF/V~ Survival outcome is better for VF than for PEA or asystole. 
Overall poor S from CA may reflect low prevalence of VFNT and contribution of other 
patient, event, and outcome factors. The large NRCPR database can identify CA factors 
associated with survival 
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870-2 Broad Dissemination of Automatic External  
Def ibr i l lators  Triples Sudden Cardiac Arrest Surv iva l  in 
a Medium-S ize  Town 
Alessandro Capocci, Massimo F. Pieooli, Daniela Aschieri, Maurizio Arvedi, Gust Bardy, 
Cardio/ogy Dept., Piacenza, Ita/y. 
Background. Sudden cardiac arrest (SCA) claims an estimated 350.000 lives per year in 
the United States, representing a major public health problem. The vast majority of SCA 
is caused by ventdcular fibrillation or pulseless ventricular tachycardia (85%) where early 
defibrillation is the most important intervention affecting survival. To improve public 
access to early defibrillation, we established "Progetto Vita" (PV), the first experience of 
out-of-hospital early defibrillation by non-medical volunteers in a medium-size European 
city. The results of the first 15-month experience of the project are here presented. Meth- 
ods. Thirty-nine semi-automatic external defibrillators (AEDs) were placed in a middle 
size European town (Piacenza, Italy, 266,531 inhabitants) distributed among 12 high-risk 
locations, 12 lay-staffed ambulances, and 15 police-cars. A total of 1,025 lay volunteers 
was trained to intervene in all cases of suspected SCA. We compared the efficacy of 
eady defibrillation by the volunteers of the PV vs. the traditional intervention of the per- 
sonnel of the Emergency Medical System (EMS). Results. During the first 15-months. 
203 codes for suspected SCA were dispatched. In 106 cases, (52%), the PV volunteers 
ardved to the scene before the EMS Ambulance (mean intervention time: 5±1 min vs. 
6±2 rain, respectively, p<0.05). Out of the 203 suspected cases, 197 were true SCAs, 
and shockable rhythms were present in 40 cases: 16 were treated by the PV volunteers 
and 7 successfully defibrillated, while 24 cases were treated by EMS staff and only 4 
cases were successfully defibrillated. The activity of the AEDs was always appropriate. 
Overall survival was 5.6% (11/197): survival improved from 2.9% (4/134) with EMS inter- 
vention to 11.1% (7/63) when the PV volunteers were activated (p<0.05). Survival rate on 
"shookable" rhythm was 43.7% in group treated by volunteers, vs. 16.6 % in those 
treated by EMS aid, p=0.06. Conclusions. Broad dissemination of AEDs. by shortening 
the intervention time, allows eady defibrillation by nonmedical volunteers and more than 
triples survival rates from out of hospital sudden cardiac arrest, with no additional risk. 
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870-3 Recurrence Patterns After Failed Defibrillation of 
Spontaneous Ventricular Fibrillation During Acute 
Ischemia 
Hao Qin, Gregory P. Walcott, Cheryl R. Killingsworth, Dennis L. Rollins, Williams M. 
Smith, Raymond E. Ideker, Cardiac Rhythm Management Lab, University of Alabama at 
Birmingham, Birmingham, Alabama. 
Background Some shocks that have halted spontaneous ventricular fibdllation (VF) dur- 
ing acute ischemia or reperfusion may seem to have failed if VF quickly recurs before the 
ECG amplifier recovers postshock. This could explain why the defibrillation threshold 
(DFT) for spontaneous VF appears markedly higher than for electrically-induced VF. 
Methods To test this hypothesis, the DFT for electdcally-induced VF (E-DFT) was deter- 
mined in 15 pigs before ischemia, followed by left anterior ascending or left circumflex 
artery occlusion. VF was electrically induced 20-min after occlusion, followed 5-min later 
by repertusion. Whether spontaneous or electrically-induced, VF during occlusion or rep- 
effusion was treated with up to 3 shocks at 1.5 times E-DFT (I.5E-DFT). If all 3 shocks 
failed, shock strength was increased. Thirty-min after reperfusion, the other artery was 
occluded and the protocol repeated. Defibdllation was considered successful if post- 
shock sinus/idioventricular hythm was present -> 30-sec. Recurrent VF within 30-sec 
after the shock was considered immediate or delayed if the first postshock activation 
complex in a rapidly restored ECG recording was VF or sinus/idioventdcular hythm, 
respectively. Results Defibrillation efficacy at 1.5E-DFT was significantly higher for elec- 
trically-induced ischemic VF (76%) than for spontaneous VF (31%). The incidence of 
delayed recurrence following electrically-induced nonischemic (3%) or ischemic (20%) 
VF was significantly lower than following spontaneous VF (75%). Mean VF recurrence 
time following spontaneous VF was 4.6~5.3 sec, The percent of recurrent VF episodes 
preceded by -> one perfusing beat, which produced a femoral systolic arterial pressure > 
30 mmHg before cardiac massage was attempted, was significantly lower for electrically- 
induced nonischemic VF (0%) than for occlusion VF (33%) or reperfusion VF (41%), but 
did not differ among electrically-induced ischemic VF (10%), occlusion VF, or reperfusioo 
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VF. Conclusion Rapid VF reinitiation after a shook that has successfully halted sponta- 
neous VF may partly be responsible for what appears to be shock failure in standard 
ECGs that take many seconds to recover postshock. 
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870-4 Immediate Termination of  F ibr i l lat ion Is More  L ike ly  
With Biphaaic Truncated Exponential Versus 
Monophasic Damped Sine Waveforms Used for External 
Defibr i l lat ion 
Oscar H. Tovar, David E. Snyder, Anu R. George, Janice L. Jones, Georgetown 
University and Veterans Affairs Medical Center, Washington, Dist. of Columbia, Philips 
Medical Systems, Seattle, Washington. 
Background: External defibdllators use either monophasic damped sinusoidal (M) or 
biphasic truncated exponential (B) waveforms. "Progressive" defibdllafion (PDF), where 
the shock is followed by postshock activations before fibrillation terminates, is more 
uncertain than "Immediate" defibrillation (IDF), where the shock immediately terminates 
fibrillation, because it can lead to either success or failure. We hypothesized that B pro- 
duce greater IDF, correlated with longer, more uniform postshock responses, than M. 
Methods: Monophasic action potentials were recorded in 5 isolated rabbit hearts. After 
10 seconds fibrillation, defibdllation was attempted with M (n=74) or 12 ms B (n=74); nor- 
malized shock coupling interval (NCI) and postshock response durations were deter- 
mined. Shock intensities were normalized to each heart's biphasic 150. 
Results: IDF probability differed significantly for M and B (see figure; p<0.001). At M 150 
for overall success, IDF probability was 0%. At B 150, probability of IDF was 40%. For M, 
response duration shortened with NCI (78.6±3.6 for NCI<40% vs 69.2 + 4.5 for 
NCI>40%; p=0.05). For B, postshock responses were independent of NCI (80.3 + 3.1 for 
NCI<40% vs 76.7 ± 2.7 for NCI>40%). 
Conclusion: M produces primarily PDF associated with nonuniform responses; B pro- 
duces primarily IDF associated with uniformly long responses independent of NCI. In 
addition to reducing threshold, B's pdmary production of IDF may contribute to its superi- 
ority for external defibrillation. 
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883 Primary Angioplasty in Acute Myocardial 
Infarction: Adjunctive Therapy 
Wednesday, March 20, 2002, 8:30 a.m.-10:00 a.m. 
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883-1 Opt imal  Reper fus ion  in Evo lv ing Myocard ia l  Infarction: 
Does Abciximab Improve Outcomes in Stent Treated 
Patients? 
Mbnica Masotti, Amadeo Betriu, Hospital Clinic, Barcelona, Spain. 
Background. Primary angioplasty (PTCA) has been found to yield better outcomes than 
thrombolysis in the early hours of acute myocardial infarction (Ml). The role of stenting in 
this setting remains controversial. Similarly, the effect of GP lib/Ilia inhibitors -now under 
intense scrutiny- remains to be clarified. 
Objective. To assess whether a combined strategy consisting in stent implantation and 
GP lib/Ilia inhibition provides better long-term outcomes than stant alone. 
Methods.Two meta-analysis were conducted. The first included 2844 patients enrolled in 
8 randomized trials comparing balloon PTCA and stenting in acute MI (FRESCO, 
ZWOLLE, GRAMI, PAMI, PASTA, STENTIM-2, PSAAMI, and CADILLAC). The second 
involved 3 randomized trials (n=1738) on stent placement with either adjunctive abcix- 
imab or placebo (ISAR-2, ADMIRAL, CADILLAC). End point was the composite of death/ 
non fatal re-MI, and target vessel revascularization (TVR) at 6 months. 
Results. Primary end-point was achieved in 14% of patients treated with stent and 26% 
of those treated with balloon PTCA (OR 0.45; 95% CI 0.37-0,55,p < 0.0001). This trans- 
lates into 120 events prevented per 1000 patients treated. Adjunctive use of abciximab in 
stent treated patients resulted in an event rate of 12% vs 16.6% without abciximab (OR 
